| Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial S Del Prato, SE Kahn, I Pavo, GJ Weerakkody, Z Yang, J Doupis, ... The Lancet 398 (10313), 1811-1824, 2021 | 385 | 2021 |
| Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery LA Vázquez, F Pazos, JR Berrazueta, C Fernández-Escalante, ... The Journal of Clinical Endocrinology & Metabolism 90 (1), 316-322, 2005 | 276 | 2005 |
| Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the … A Goday, E Calvo, LA Vázquez, E Caveda, T Margallo, ... BMC public health 16, 1-14, 2016 | 98 | 2016 |
| Impact of frailty in older patients with diabetes mellitus: An overview A Cobo, LA Vázquez, J Reviriego, L Rodríguez-Mañas Endocrinología y Nutrición (English Edition) 63 (6), 291-303, 2016 | 66 | 2016 |
| Association of ACACB polymorphisms with obesity and diabetes JA Riancho, L Vázquez, MA Garcia-Perez, J Sainz, JM Olmos, ... Molecular genetics and metabolism 104 (4), 670-676, 2011 | 58 | 2011 |
| Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the … LA Vázquez, Á Rodríguez, J Salvador, JF Ascaso, H Petto, J Reviriego BMC cardiovascular disorders 14, 1-8, 2014 | 53 | 2014 |
| Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up MT Garcia-Unzueta, R Fernández-Santiago, A Domínguez-Díez, ... Obesity surgery 15 (2), 187-190, 2005 | 49 | 2005 |
| Mineral metabolism in obese patients following vertical banded gastroplasty JM Olmos, LA Vázquez, JA Amado, JL Hernández, J González Macías Obesity surgery 18, 197-203, 2008 | 40 | 2008 |
| Social economic costs of type 1 diabetes mellitus in pediatric patients in Spain: CHRYSTAL observational study J Lopez-Bastida, JP López-Siguero, J Oliva-Moreno, M Perez-Nieves, ... Diabetes research and clinical practice 127, 59-69, 2017 | 39 | 2017 |
| Health-related quality of life in type 1 diabetes mellitus pediatric patients and their caregivers in Spain: an observational cross-sectional study J López-Bastida, JP López-Siguero, J Oliva-Moreno, LA Vázquez, ... Current medical research and opinion, 2019 | 30 | 2019 |
| Cortisol and adrenal androgens as independent predictors of mortality in septic patients R De Castro, D Ruiz, BA Lavín, JÁ Lamsfus, L Vázquez, C Montalban, ... PLoS One 14 (4), e0214312, 2019 | 23 | 2019 |
| Prevalence of impaired fasting glucose and type 1 and 2 diabetes mellitus in a large nationwide working population in Spain J Reviriego, LA Vázquez, A Goday, M Cabrera, MT García-Margallo, ... Endocrinología y Nutrición 63 (4), 157-163, 2016 | 21 | 2016 |
| Blood glucose control and quality of health care in non‐insulin‐treated patients with Type 2 diabetes in Spain: a retrospective and cross‐sectional observational study A Rodríguez, A Calle, L Vázquez, F Chacón, P Polavieja, J Reviriego, ... Diabetic medicine 28 (6), 731-740, 2011 | 21 | 2011 |
| Decreased plasma endothelin-1 levels in asymptomatic type I diabetic patients with regional cerebral hypoperfusion assessed by Spect LA Vázquez, JA Amado, MT Garcı́a-Unzueta, R Quirce, ... Journal of Diabetes and its Complications 13 (5-6), 325-331, 1999 | 18 | 1999 |
| Incidence of diabetes in the working population in Spain: results from the ICARIA cohort LA Vazquez, E Calvo-Bonacho, J Reviriego, T García-Margallo, E Caveda, ... Diabetes Therapy 10, 57-69, 2019 | 12 | 2019 |
| Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index R Gentilella, G Sesti, L Vazquez, H Sapin, V Reed, I Romera, P Pozzilli Diabetes, Obesity and Metabolism 21 (12), 2660-2666, 2019 | 10 | 2019 |
| Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents R Gentilella, I Romera, C Nicolay, R Buzzetti, LA Vázquez, G Sesti Diabetes Therapy 10, 1113-1125, 2019 | 10 | 2019 |
| Achieving normoglycemia with tirzepatide: analysis of SURPASS 1–4 trials J Rosenstock, L Vázquez, S Del Prato, DR Franco, G Weerakkody, B Dai, ... Diabetes care 46 (11), 1986-1992, 2023 | 7 | 2023 |
| 90-LB: Characterization of Tirzepatide-Treated patients achieving HbA1c< 5.7% in the SURPASS 1-4 Trials J Rosenstock, S Del Prato, DR Franco, LA Vazquez, B Dai, ... Diabetes 71 (Supplement_1), 2022 | 7 | 2022 |
| Bone mineral density evolution and incidence of fractures in a cohort of patients with primary hyperparathyroidism treated with parathyroid surgery vs active surveillance … L Ramos, M Piedra, P Muñoz, LA Vázquez, MT García-Unzueta, ... Endocrinología, Diabetes y Nutrición (English ed.) 66 (1), 41-48, 2019 | 6 | 2019 |
